Computational insights on the molecular interplay between KRas (G12D mutation) and SOS1 modulated by the inhibitor BI-3406
PLOS Computational Biology · 2026
DOI: 10.1371/journal.pcbi.1014213 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Computational Biology, 2026. Verfasst von Juan Zeng und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomedical Engineering, Guangdong Medical University, Dongguan, China. Hauptthemen laut MEDLINE: SOS1 Protein, Proto-Oncogene Proteins p21(ras). Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Guangdong Province, Guangdong Medical University Undergraduate Innovation and Entrepreneurship Education Base Project.
Abstract (Originalsprache)
Ras proteins are prominent oncogenes, with KRas mutations found in approximately 80% of cancer cells harboring Ras mutations. The mechanism by which Ras mutations cause cancer remains unclear. Human Son of Sevenless (SOS) promotes the GDP-to-GTP exchange in the inactive GDP-bound Ras (RasGDP) by interacting with RasGDP conformation, thereby leading to the development of human cancer. Elucidating the Ras-SOS interaction mechanism can guide the drug design for Ras and SOS proteins. Based on our previously sampled special structure KRasGDP·Mg 2+ S1.2 , this study constructs a functional ternary complex (KRasGDP·Mg 2+ )·SOS1·(KRasGTP·Mg 2+ ). Furthermore, the KRas-SOS1 interactions regulated by the KRas G12D mutation and the SOS1 inhibitor BI-3406 that reportedly exhibits synergistic effects with G12D-mutant Ras inhibitors, are investigated through molecular dynamics (MD) simulations. The findings reveal that the G12D mutation and BI-3406 both affect the KRas-SOS1 interaction via the Switch-II (SW2) region of KRas. The negatively charged Asp12 has a repulsive effect on KRas, particularly on SW2, altering the interfacial electrostatic landscapes and diminishing the binding affinities by approximately 25 kcal/mol for both KRasGDP·Mg 2+ and KRasGTP·Mg 2+ . BI-3406 forms a hydrogen-bond bridge between SW2 and SOS1 in wild type (WT) KRas, interrupting the interactions among the N-terminal residues of SW2 and SOS1. Moreover, BI-3406 was found here to attenuate the binding affinity of both WT and G12D-mutant KRasGDP·Mg 2+ to SOS1. Interestingly, BI-3406 hardly affects the binding affinity of WT KRasGTP·Mg 2+ , while enhances the binding affinity of G12D-mutant KRasGTP·Mg 2+ . The change of binding affinity makes the catalytic pocket of SOS1 prefer to KRasGTP·Mg 2+ and inhibits the growth of G12D-mutant KRas-driven tumors. These mechanistic insights provide valuable information for designing SOS1-co-targeting inhibitors to potentiate antitumor efficacy against G12D-mutated KRas.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Biomedical Engineering, Guangdong Medical University, Dongguan, China.
- Shanghai Engineering Research Center of Molecular Therapeutics and New Drug Development, School of Chemistry and Molecular Engineering, East China Normal University, Shanghai, China.
- NYU-ECNU Center for Computational Chemistry at NYU Shanghai, Shanghai, China.
ORCID-Profile: Juan Zeng
Förderung
- Natural Science Foundation of Guangdong Province
- Guangdong Medical University Undergraduate Innovation and Entrepreneurship Education Base Project
Zitieren
APA
Zeng, J., Lan, Y., & Xia, F. (2026). Computational insights on the molecular interplay between KRas (G12D mutation) and SOS1 modulated by the inhibitor BI-3406. PLOS Computational Biology. https://doi.org/10.1371/journal.pcbi.1014213
Vancouver
Zeng J, Lan Y, Xia F. Computational insights on the molecular interplay between KRas (G12D mutation) and SOS1 modulated by the inhibitor BI-3406. PLOS Computational Biology. 2026. doi:10.1371/journal.pcbi.1014213
BibTeX
@article{Zeng2026,
author = {Zeng, Juan and Lan, Yixuan and Xia, Fei},
title = {Computational insights on the molecular interplay between KRas (G12D mutation) and SOS1 modulated by the inhibitor BI-3406},
journal = {PLOS Computational Biology},
year = {2026},
doi = {10.1371/journal.pcbi.1014213}
}
EUVIMED